Skip to main content
. 2022 Sep 8;12:974029. doi: 10.3389/fonc.2022.974029

Figure 1.

Figure 1

Flow Chart. A total of 82 patients were treated with CAR T-cell therapy at our site starting from Jan. 2019 to Feb. 2022. 11 patients were excluded because of entities other than lymphoma, 29 patients did not have a baseline PET/CT examination near before CAR T-cell transfusion, and 5 patients were excluded because of lack of survival documentation, and 3 patients did not have a measurable lesion according to the Lugano criteria or a hypermetabolic lesion.